Azacitidine for treating acute myeloid leukaemia with more than 30 % bone marrow blasts: An Evidence Review Group perspective of a National Institute for Health and Care Excellence Single Technology Appraisal
Irina A. Tikhonova, Martin W. Hoyle, Tristan M. Snowsill, Chris Cooper, Joanna L. Varley-Campbell, Claudius E. Rudin, Ruben E. Mujica Mota
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Azacitidine for treating acute myeloid leukaemia with more than 30 % bone marrow blasts: An Evidence Review Group perspective of a National Institute for Health and Care Excellence Single Technology Appraisal'. Together they form a unique fingerprint.